L. Rahib, B. D. Smith, R. Aizenberg, A. B. Rosenzweig, J. M. Fleshman et al., Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States, Cancer Res, 2014.

A. Vincent, J. Herman, R. Schulick, R. H. Hruban, M. Goggins et al., Lancet, vol.378, pp.607-620, 2011.

J. Kleeff, M. Korc, M. Apte, C. La-vecchia, C. D. Johnson et al.,

M. Amrutkar and I. P. Gladhaug, Pancreatic Cancer Chemoresistance to Gemcitabine, vol.9, 2017.

. Tcga-network, Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma, Cancer Cell, vol.32, pp.185-203, 2017.

D. R. Principe, J. A. Doll, J. Bauer, B. Jung, H. G. Munshi et al., TGF-beta: Duality of function between tumor prevention and carcinogenesis, J. Natl. Cancer Inst, vol.106, 2014.

R. Derynck, R. J. Akhurst, and A. Balmain, TGF-beta signaling in tumor suppression and cancer progression, Nat. Genet, vol.29, pp.117-129, 2001.

N. Jonckheere, M. Perrais, C. Mariette, S. K. Batra, J. P. Aubert et al., A role for human MUC4 mucin gene, the ErbB2 ligand, as a target of TGF-beta in pancreatic carcinogenesis, Oncogene, vol.23, pp.5729-5738, 2004.

N. Skrypek, B. Duchene, M. Hebbar, E. Leteurtre, I. Van-seuningen et al., The MUC4 mucin mediates gemcitabine resistance of human pancreatic cancer cells via the Concentrative Nucleoside Transporter family, Oncogene, vol.32, pp.1714-1723, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00807837

M. Schutte, R. H. Hruban, L. Hedrick, K. R. Cho, G. M. Nadasdy et al., Cancer Res, vol.56, pp.2527-2530, 1996.

A. Voulgari and A. Pintzas, Epithelial-mesenchymal transition in cancer metastasis: Mechanisms, markers and strategies to overcome drug resistance in the clinic, Biochim. Biophys. Acta, vol.1796, pp.75-90, 2009.

R. J. Akhurst and R. Derynck, TGF-beta signaling in cancer-A double-edged sword, Trends Cell Biol, vol.11, pp.44-51, 2001.

H. Ijichi, A. Chytil, A. E. Gorska, M. E. Aakre, Y. Fujitani et al., Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression, Genes Dev, vol.20, pp.3147-3160, 2006.

K. T. Ostapoff, B. K. Cenik, M. Wang, R. Ye, X. Xu et al., Neutralizing murine TGFbetaR2 promotes a differentiated tumor cell phenotype and inhibits pancreatic cancer metastasis, Cancer Res, vol.74, pp.4996-5007, 2014.

J. Li, H. Liang, M. Bai, T. Ning, C. Wang et al., miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer, PLoS ONE, vol.10, 2015.

P. Ullmann, F. Rodriguez, M. Schmitz, S. K. Meurer, K. Qureshi-baig et al., The miR-371 approximately 373 Cluster Represses Colon Cancer Initiation and Metastatic Colonization by Inhibiting the TGFBR2/ID1 Signaling Axis, Cancer Res, vol.78, pp.3793-3808, 2018.

N. Sahu, E. Chan, F. Chu, T. Pham, H. Koeppen et al., Cotargeting of MEK and PDGFR/STAT3 Pathways to Treat Pancreatic Ductal Adenocarcinoma, Mol. Cancer Ther, vol.16, pp.1729-1738, 2017.

N. S. Nagathihalli, J. A. Castellanos, C. Shi, Y. Beesetty, M. L. Reyzer et al., Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer, Gastroenterology, vol.149, pp.1932-1943, 2015.

H. R. Qin, H. J. Kim, J. Y. Kim, E. M. Hurt, G. J. Klarmann et al., Activation of signal transducer and activator of transcription 3 through a phosphomimetic serine 727 promotes prostate tumorigenesis independent of tyrosine 705 phosphorylation, Cancer Res, vol.68, pp.7736-7741, 2008.

K. Venkatasubbarao, L. Peterson, S. Zhao, P. Hill, L. Cao et al., Inhibiting signal transducer and activator of transcription-3 increases response to gemcitabine and delays progression of pancreatic cancer, Mol. Cancer, vol.12, 2013.

K. Miyabayashi, H. Ijichi, D. Mohri, M. Tada, K. Yamamoto et al., Erlotinib prolongs survival in pancreatic cancer by blocking gemcitabine-induced MAPK signals, Cancer Res, vol.73, pp.2221-2234, 2013.

M. J. Moore, D. Goldstein, J. Hamm, A. Figer, J. R. Hecht et al., Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada Clinical Trials Group, J. Clin. Oncol, vol.25, pp.1960-1966, 2007.

L. J. Barber, J. M. Rosa-rosa, I. Kozarewa, K. Fenwick, I. Assiotis et al., Comprehensive genomic analysis of a BRCA2 deficient human pancreatic cancer, PLoS ONE, vol.6, 2011.

E. L. Deer, J. Gonzalez-hernandez, J. D. Coursen, J. E. Shea, J. Ngatia et al., Phenotype and genotype of pancreatic cancer cell lines, Pancreas, vol.39, pp.425-435, 2010.

B. L. Bryson, D. J. Junk, R. Cipriano, and M. W. Jackson, STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence, Cell Cycle, vol.16, pp.319-334, 2017.

A. Kali, Y. O. Ostapchuk, and N. N. Belyaev, TNFalpha and TGFbeta-1 synergistically increase the cancer stem cell properties of MiaPaCa-2 cells, Oncol. Lett, vol.14, pp.4647-4658, 2017.

S. Busch, A. H. Sims, O. Stal, M. Ferno, and G. Landberg, Loss of TGFbeta Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance, Cancer Res, vol.75, pp.1457-1469, 2015.

M. K. Wendt, T. M. Allington, and W. P. Schiemann, Mechanisms of the epithelial-mesenchymal transition by TGF-beta, Future Oncol, vol.5, pp.1145-1168, 2009.

D. J. Junk, B. L. Bryson, J. M. Smigiel, N. Parameswaran, C. A. Bartel et al., Oncostatin M promotes cancer cell plasticity through cooperative STAT3-SMAD3 signaling, vol.36, pp.4001-4013, 2017.

Y. S. Wu, I. Chung, W. F. Wong, A. Masamune, M. S. Sim et al., Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells, Biochim. Biophys. Acta, vol.1861, pp.296-306, 2017.

N. Jonckheere, N. Skrypek, J. Merlin, A. F. Dessein, P. Dumont et al., The mucin MUC4 and its membrane partner ErbB2 regulate biological properties of human CAPAN-2 pancreatic cancer cells via different signalling pathways, PLoS ONE, vol.7, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00807830

I. Van-seuningen, M. Perrais, P. Pigny, N. Porchet, and J. P. Aubert, Sequence of the 5 -flanking region and promoter activity of the human mucin gene MUC5B in different phenotypes of colon cancer cells, Biochem. J, vol.348, pp.675-686, 2000.

P. Mesquita, N. Jonckheere, R. Almeida, M. P. Ducourouble, J. Serpa et al., Human MUC2 mucin gene is transcriptionally regulated by Cdx homeodomain proteins in gastrointestinal carcinoma cell lines, J. Biol. Chem, vol.278, pp.51549-51556, 2003.

I. Van-seuningen, J. Ostrowski, X. R. Bustelo, P. R. Sleath, and K. Bomsztyk, The K protein domain that recruits the interleukin 1-responsive K protein kinase lies adjacent to a cluster of c-Src and Vav SH3-binding sites. Implications that K protein acts as a docking platform, J. Biol. Chem, vol.270, pp.26976-26985, 1995.

N. Jonckheere, V. Fauquette, L. Stechly, N. Saint-laurent, S. Aubert et al., Tumour growth and resistance to gemcitabine of pancreatic cancer cells are decreased by AP-2alpha overexpression, Br. J. Cancer, vol.101, pp.637-644, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00410436

G. Piessen, N. Jonckheere, A. Vincent, B. Hemon, M. P. Ducourouble et al., Regulation of the human mucin MUC4 by taurodeoxycholic and taurochenodeoxycholic bile acids in oesophageal cancer cells is mediated by hepatocyte nuclear factor 1alpha, Biochem. J, vol.402, pp.81-91, 2007.
URL : https://hal.archives-ouvertes.fr/hal-00478670

M. Van-der-sluis, M. H. Melis, N. Jonckheere, M. P. Ducourouble, H. A. Buller et al., The murine Muc2 mucin gene is transcriptionally regulated by the zinc-finger GATA-4 transcription factor in intestinal cells, Biochem. Biophys. Res. Commun, vol.325, pp.952-960, 2004.

E. Cerami, J. Gao, U. Dogrusoz, B. E. Gross, S. O. Sumer et al., The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data, Cancer Discov, vol.2, pp.401-404, 2012.

J. Gao, B. A. Aksoy, U. Dogrusoz, G. Dresdner, B. Gross et al., Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal, Sci. Signal, issue.6, 2013.

J. Barretina, G. Caponigro, N. Stransky, K. Venkatesan, A. A. Margolin et al., The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity, Nature, vol.483, pp.603-607, 2012.